Mrna Flu Vaccine News

The U.S. Food and Drug Administration (FDA) has approved mFlusiva, the first mRNA-based influenza vaccine developed by Moderna, for individuals aged 50 and olde

The FDA has approved Moderna's mRNA seasonal flu vaccine, despite initially refusing to review it.

The FDA has approved the first mRNA flu vaccine for older adults, developed by Moderna, months after facing criticism for its initial refusal to review the shot

The F.D.A. has approved Moderna's mRNA flu vaccine, reversing its initial refusal to review the application following a significant public outcry.